Holen Sie sich die Stockscreener-App
2.8776
2.60%
-0.0767
Schlusskurs vom Vortag:
$2.9543
Offen:
$3.1942
24-Stunden-Volumen:
3,155
Relative Volume:
0.47
Marktkapitalisierung:
$4.30M
Einnahmen:
$5.67M
Nettoeinkommen (Verlust:
$-13.98M
KGV:
-0.2037
EPS:
-14.13
Netto-Cashflow:
$-15.30M
1W Leistung:
-8.65%
1M Leistung:
-8.65%
6M Leistung:
-16.71%
1J Leistung:
+39.69%
1-Tages-Spanne:
$2.8655
$3.1942
1-Wochen-Bereich:
$2.74
$3.20
52-Wochen-Spanne:
$1.9001
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Firmenname
Arcadia Biosciences Inc
Sektor
Branche
Telefon
530-756-7077
Adresse
202 COUSTEAU PLACE, DAVIS, CA
Vergleichen Sie RKDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
2.8776 | 4.30M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
29.94 | 36.06B | 25.85B | 2.74B | 3.02B | 2.26 |
|
GIS
General Mills Inc
|
57.67 | 32.31B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.41 | 28.46B | 12.75B | 1.34B | 1.13B | 3.87 |
|
MKC
Mccormick Co Inc
|
74.67 | 20.81B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
30.40 | 16.80B | 11.92B | 805.04M | 1.01B | 1.46 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-12 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | Eingeleitet | Credit Suisse | Outperform |
| 2015-06-09 | Eingeleitet | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Aktie (RKDA) Neueste Nachrichten
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Arcadia Biosciences regains IP rights, amends agreement - Investing.com
Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener
Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com UK
Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World
Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock - MSN
Arcadia Biosciences Earnings Call Highlights Zola Growth - TipRanks
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ... - Yahoo Finance
Arcadia Biosciences Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: Arcadia Biosciences Q4 2024 sees revenue growth By Investing.com - Investing.com Canada
Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow
Arcadia Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights - Quantisnow
Arcadia Biosciences (RKDA) Expected to Announce Earnings on Thursday - Defense World
Arcadia Biosciences Crushes Q4 Expectations: 124% Growth in Zola Brand Powers Record Revenue - Stock Titan
Arcadia Biosciences Inc expected to post a loss of 89 cents a shareEarnings Preview - TradingView
Arcadia Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call - Business Wire
Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders - Business Wire
Arcadia Biosciences CFO Kawakami buys $1,743 in stock - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerEVGR, QTRX, RKDA, EBTC - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC - GlobeNewswire Inc.
Arcadia Biosciences CEO Thomas Schaefer buys $1,743 in stock By Investing.com - Investing.com South Africa
Arcadia Biosciences CFO Kawakami buys $1,743 in stock By Investing.com - Investing.com Canada
Chief Financial Officer Kawakami Mark bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 35% to 2,681 units (SEC Form 4) - Quantisnow
Chief Executive Officer Schaefer Thomas J. bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 33% to 2,819 units (SEC Form 4) - Quantisnow
StockNews.com Begins Coverage on Arcadia Biosciences (NASDAQ:RKDA) - Armenian Reporter
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com - Defense World
Finanzdaten der Arcadia Biosciences Inc-Aktie (RKDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):